CoChat

Identification of ApoB-Containing Lipoprotein Families in NIDDM

Alaupovic, Peter, Bard, Jean-Marie, Tavella, Marcelo, Shafer, David · 1992 · Diabetes
Cited by 33

The DOI matches its Crossref record.

Abstract

The purpose of this study was to determine the concentrations and composition of apoB-containing lipoprotein families in whole plasma and major lipoprotein density classes of a selected group of Native Americans from northeastern Oklahoma with non-insulin-dependent diabetes mellitus. The measurement of lipoprotein density classes showed that the total lipoprotein mass of very-low-density lipoproteins was significantly higher and that of high-density lipoproteins significantly lower in diabetic patients than nondiabetic control subjects regardless of their plasma triglyceride levels. The VLDLs were enriched with TG, free cholesterol, and apolipoproteins C-III and E. HDLs were enriched with TG but depleted of apoC-III and apoE. There was no change in the levels of TG-enriched low-density lipoproteins. Fractionation of VLDL by sequential immunoprecipitation with antisera to apoE and apoC-III established that increased concentrations of this density class in diabetic patients are due to elevated levels of TG-rich lipoprotein LP-B:C and lipoprotein LP-B:C:E. The levels of LP-B:C particles were increased more than the levels of LP-B:C:E particles. The LDLs were characterized by a slight increase in TG-enriched lipoprotein B and no change in the levels of LP-B:C and LP-B:C:E. There was no difference between diabetic patients with or without vascular disease in the levels of LP-B and LP-B:C:E. However, patients with vascular disease had higher concentrations of LP-B:C particles in VLDL and whole plasma than patients without vascular disease. In conclusion, the most characteristic abnormalities of lipid transport in people with NIDDM are increased levels of TG-rich LP-B:C and LP-B:C:E particles of modified chemical composition and decreased concentrations of apoA-l-containing lipoproteins of modified chemical composition. These abnormalities seem to be present in most diabetic patients regardless of their plasma TG levels. It appears that diabetic patients with vascular disease have higher levels of LP-B:C particles and higher LP-B:C-LP-B:C:E ratios than diabetic patients without vascular disease. The metabolic behavior and atherogenic potential of LP-B:C and other TG-rich apoB-containing lipoproteins remain to be ascertained in future studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.41.2.s18

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 33

Metadata

Authors
Alaupovic, P., Bard, J.-M., Tavella, M., & Shafer, D.
Venue
Diabetes
Published
1992-10-01
Volume
41
Issue
Supplement_2
Pages
18-25
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2335398866
Cited by
33
References
0
FWCI
0.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of ApoB-Containing Lipoprotein Families in NIDDM. https://app.cochat.ai/papers/10.2337/diab.41.2.s18
The paper
Alaupovic, P., Bard, J.-M., Tavella, M., & Shafer, D. (1992). Identification of ApoB-Containing Lipoprotein Families in NIDDM. Diabetes. https://doi.org/10.2337/diab.41.2.s18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.